Clover Health Investments (CLOV) Competitors $2.75 -0.04 (-1.43%) Closing price 04:00 PM EasternExtended Trading$2.78 +0.02 (+0.91%) As of 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLOV vs. ACT, OSCR, BWIN, FG, PLMR, GSHD, HGTY, BHF, LMND, and NMIHShould you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Enact (ACT), Oscar Health (OSCR), Baldwin Insurance Group (BWIN), F&G Annuities & Life (FG), Palomar (PLMR), Goosehead Insurance (GSHD), Hagerty (HGTY), Brighthouse Financial (BHF), Lemonade (LMND), and NMI (NMIH). These companies are all part of the "insurance" industry. Clover Health Investments vs. Its Competitors Enact Oscar Health Baldwin Insurance Group F&G Annuities & Life Palomar Goosehead Insurance Hagerty Brighthouse Financial Lemonade NMI Clover Health Investments (NASDAQ:CLOV) and Enact (NASDAQ:ACT) are both insurance companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends. Which has more volatility and risk, CLOV or ACT? Clover Health Investments has a beta of 1.92, indicating that its share price is 92% more volatile than the S&P 500. Comparatively, Enact has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Do analysts rate CLOV or ACT? Clover Health Investments currently has a consensus price target of $4.83, suggesting a potential upside of 75.76%. Given Clover Health Investments' stronger consensus rating and higher possible upside, research analysts clearly believe Clover Health Investments is more favorable than Enact.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clover Health Investments 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Enact 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals hold more shares of CLOV or ACT? 19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 18.0% of Enact shares are owned by institutional investors. 24.1% of Clover Health Investments shares are owned by insiders. Comparatively, 0.4% of Enact shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has stronger earnings and valuation, CLOV or ACT? Enact has lower revenue, but higher earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Enact, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClover Health Investments$1.37B1.02-$43.01M-$0.05-55.00Enact$1.20B4.70$688.07M$4.448.48 Is CLOV or ACT more profitable? Enact has a net margin of 56.93% compared to Clover Health Investments' net margin of -1.69%. Enact's return on equity of 14.44% beat Clover Health Investments' return on equity.Company Net Margins Return on Equity Return on Assets Clover Health Investments-1.69% -7.42% -4.00% Enact 56.93%14.44%11.01% Does the media prefer CLOV or ACT? In the previous week, Enact had 14 more articles in the media than Clover Health Investments. MarketBeat recorded 16 mentions for Enact and 2 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.93 beat Enact's score of 0.04 indicating that Clover Health Investments is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Enact 4 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryClover Health Investments and Enact tied by winning 8 of the 16 factors compared between the two stocks. Get Clover Health Investments News Delivered to You Automatically Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLOV vs. The Competition Export to ExcelMetricClover Health InvestmentsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.40B$1.99B$5.52B$8.86BDividend YieldN/AN/A5.36%4.13%P/E Ratio-55.0038.5126.3919.77Price / Sales1.0215.49408.83110.45Price / CashN/A56.2225.8827.49Price / Book4.048.657.915.36Net Income-$43.01M-$63.71M$3.15B$248.34M7 Day Performance-3.17%0.19%1.04%1.28%1 Month Performance-13.52%3.56%5.36%5.45%1 Year Performance129.17%4.23%32.71%18.02% Clover Health Investments Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLOVClover Health Investments2.2167 of 5 stars$2.75-1.4%$4.83+75.8%+126.8%$1.40B$1.37B-55.00680News CoverageACTEnactN/A$37.33+2.9%$35.00-6.2%+21.2%$5.60B$1.20B8.41500OSCROscar Health1.458 of 5 stars$20.38-4.0%$16.50-19.0%+36.1%$5.19B$9.18B72.792,400High Trading VolumeBWINBaldwin Insurance Group1.7741 of 5 stars$41.86+4.9%$44.83+7.1%+20.7%$4.96B$1.39B-80.504,116Analyst UpgradeHigh Trading VolumeFGF&G Annuities & Life4.0467 of 5 stars$32.00+1.2%$44.33+38.5%-16.1%$4.31B$4.76B8.491,338News CoveragePLMRPalomar3.8114 of 5 stars$160.06+2.8%$164.33+2.7%+90.1%$4.28B$609.96M31.95150News CoverageAnalyst ForecastGSHDGoosehead Insurance3.7423 of 5 stars$101.76+2.8%$115.40+13.4%+83.7%$3.82B$325.63M85.511,580Positive NewsHGTYHagerty1.0602 of 5 stars$10.05+2.0%$10.50+4.5%-3.0%$3.43B$1.20B50.251,744BHFBrighthouse Financial4.4561 of 5 stars$58.89+0.1%$60.80+3.2%+24.1%$3.38B$4.72B7.061,400LMNDLemonade1.9713 of 5 stars$45.90+3.6%$28.17-38.6%+165.9%$3.36B$558.60M-15.101,235News CoverageAnalyst ForecastHigh Trading VolumeNMIHNMI2.1114 of 5 stars$41.88+2.5%$42.29+1.0%+23.9%$3.27B$650.97M9.05234 Related Companies and Tools Related Companies Enact Alternatives Oscar Health Alternatives Baldwin Insurance Group Alternatives F&G Annuities & Life Alternatives Palomar Alternatives Goosehead Insurance Alternatives Hagerty Alternatives Brighthouse Financial Alternatives Lemonade Alternatives NMI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLOV) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
